GlassScriptPhysician profile
Roman Marchenko
NPI 1679924880
$29,742.01
in general payments reported to CMS, 2019-2025
22 companies · $5,318 in 2025
The $5,318 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $49.99 · 2021: $1,097 · 2022: $14K · 2023: $978 · 2024: $8,341 · 2025: $5,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,501 · Travel and Lodging: $6,045 · Grant: $2,000 · Education: $90.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,501.06 |
| Travel and Lodging | $6,045.31 |
| Grant | $2,000.00 |
| Education | $90.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19,374.65 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $5,662.04 | 2022-2025 | Emblem Mri S-Icd, Farapulse, General - Therapies |
| Abbott Laboratories | $3,285.39 | 2019-2025 | Ensite, Aveir, Agilis Hispro |
| Atricure, INC. | $196.59 | 2022-2024 | |
| Amgen INC. | $192.98 | 2022-2025 | Repatha, Repatha |
| Pfizer INC. | $115.56 | 2023-2025 | |
| Cardiva Medical, INC. | $102.42 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| E.R. Squibb & Sons, L.L.C. | $101.40 | 2019-2024 | Camzyos, Eliquis |
| Philips North America LLC | $93.31 | 2022 | |
| Janssen Pharmaceuticals, INC | $89.70 | 2019-2024 | Xarelto |
| Biotronik INC. | $89.36 | 2024-2025 | Biomonitor, Amvia Edge |
| Abiomed | $85.96 | 2020-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $62.21 | 2024-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $55.00 | 2023 | Optimizer |
| Scpharmaceuticals INC. | $50.21 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $34.78 | 2019-2025 | Farxiga |
| Ethicon US, LLC | $31.15 | 2023 | Stratafix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.14 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $29.12 | 2025 | |
| Stryker Corporation | $22.31 | 2025 | Clottriever Bold Catheter |
| Biosense Webster, INC. | $20.17 | 2023 | Carto 3 |
| Teleflex LLC | $17.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roman Marchenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.